Published in J Am Soc Nephrol on July 28, 2014
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
Rejection of the kidney allograft. N Engl J Med (2010) 3.30
Delayed graft function in kidney transplantation. Lancet (2004) 3.06
Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
Mechanisms of rejection: current perspectives. Transplantation (2012) 2.19
Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol (2011) 1.67
IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality. Kidney Int (2012) 1.59
Double versus single renal allografts from aged donors. Transplantation (2000) 1.58
Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant (2004) 1.54
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) (2002) 1.40
Presensitization and kidney transplant failures. Postgrad Med J (1971) 1.33
Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost (2008) 1.29
Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol (2008) 1.23
Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum (2006) 1.19
The significance of autoantibodies against β2-glycoprotein I. Blood (2012) 1.15
Can graft endothelial cells initiate a host anti-graft immune response? Transplantation (1996) 1.12
Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation (1999) 1.08
Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis (2006) 1.07
Renal allograft thrombosis. Nephrol Dial Transplant (2009) 1.06
Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol (1997) 1.03
The antiphospholipid syndrome. Semin Nephrol (2007) 1.01
Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome. Arthritis Rheum (2013) 0.96
Pathogenesis of the antiphospholipid syndrome. Semin Thromb Hemost (2012) 0.94
Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study. Nephrol Dial Transplant (2012) 0.94
beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin. J Clin Invest (1998) 0.93
Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol (2011) 0.91
Role of non-HLA antibodies in organ transplantation. Curr Opin Organ Transplant (2012) 0.89
"Old-for-old" cadaveric renal transplantation: surgical findings, perioperative complications and outcome. Eur Urol (2003) 0.89
Mechanisms and role of HLA and non-HLA alloantibodies. Clin J Am Soc Nephrol (2006) 0.87
Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature. J Transplant (2012) 0.87
Renal allograft loss in the first post-operative month: causes and consequences. Clin Transplant (2012) 0.86
Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis. Kidney Int (1995) 0.86
Antiphospholipid antibodies. Arch Pathol Lab Med (2002) 0.86
Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells. Thromb Haemost (2001) 0.84
Renal transplantation in the modern immunosuppressive era in Spain: four-year results from a multicenter database focus on post-transplant cardiovascular disease. Kidney Int Suppl (2008) 0.84
Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection. Clin J Am Soc Nephrol (2008) 0.84
Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Lupus (2003) 0.84
Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation (2010) 0.83
Receptors involved in cell activation by antiphospholipid antibodies. Thromb Res (2013) 0.82
Anti-beta 2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells. Isr Med Assoc J (2000) 0.82
Heterogeneity between diagnostic tests for IgA anti-beta2 glycoprotein I: explaining the controversy in studies of association with vascular pathology. Anal Chem (2013) 0.82
Infections and vaccines in the etiology of antiphospholipid syndrome. Curr Opin Rheumatol (2012) 0.82
Isolated IgA anti- β2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome. J Immunol Res (2014) 0.82
A glow of HLA typing in organ transplantation. Clin Transl Med (2013) 0.81
Identification of beta2-glycoprotein I as a membrane-associated protein in kidney: purification by calmodulin affinity chromatography. Biochim Biophys Acta (1997) 0.81
Hemodialysis duration, human platelet antigen HPA-3 and IgA isotype of anti-β2glycoprotein I antibodies are associated with native arteriovenous fistula failure in Tunisian hemodialysis patients. Thromb Res (2013) 0.80
Renal transplantation dramatically reduces IgA anti-beta-2-glycoprotein I antibodies in patients with endstage renal disease. J Immunol Res (2014) 0.79
Clinical significance of antiphospholipid antibodies on allograft and patient outcome after kidney transplantation. Transplant Proc (2005) 0.79
The clinical significance of antibody to vascular endothelial cells after renal transplantation. Clin Transplant (2002) 0.79
Raised concentrations of antibodies to cardiolipin in patients receiving dialysis. BMJ (1990) 0.78
Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation (1999) 0.77
RT-PCR and in situ hybridization analysis of apolipoprotein H expression in rat normal tissues. Int J Mol Med (2006) 0.77
Renal thrombotic microangiopathy revisited: when a lesion is not a clinical finding. Saudi J Kidney Dis Transpl (2010) 0.76